Clinical Trial Expertise BCI is a specialized biostatistical consulting firm with extensive experience across all phases of clinical trials (Phase 1 to Phase 4) and regulatory submissions (INDs, NDAs, BLAs, IDEs, PMAs, 510(k)s). This positions them as a potential partner for sponsors seeking robust statistical design, analysis, and regulatory-ready deliverables.

Full Service Offering From study design and sample size calculations to analysis, RAPID SAS programming, writing statistical sections, and integrated efficacy/safety summaries, BCI offers end-to-end statistical support, enabling a single vendor to manage multiple regulatory-ready outputs.

Regulatory Alignment With experience producing statistical representations for FDA and European agencies and participation in Data Monitoring Committees, BCI can help clients navigate regulatory expectations and accelerate time to submission.

Boutique Scale Advantage BCI operates with a select group of highly experienced statisticians and programmers, suggesting a premium, personalized service with potential for agile collaboration and high-touch support attractive to mid-market biotech and specialty pharma clients.

Growth and Opportunity Revenue range indicates a growing firm with room to scale alongside mid-sized sponsors seeking specialized biostatistical support; cross-sell services such as statistical programming, trial design optimization, and integrated safety analyses to expand wallet share.